Search Browse Earnings

OPKO HEALTH, INC.

Nasdaq:OPK

Pharmaceutical Preparations·MIAMI, FL

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$863.5M

-14.0% YoY

FY 2025

Adj. EBITDA

-$51.7M

-6.0% margin

FY 2025

Net Income

-$188.9M

-21.9% margin

FY 2025

EPS (Diluted)

-$0.25

FY 2025

Stock Price

$1.16

-4.2%

2026-03-11

52W Range

$1.11 – $1.95

P/E Ratio

-4.7x

Market Cap

$883.6M

Cash

$426.6M

FY 2025

Total Debt

$3.0M

FY 2025

Net Cash

$423.6M

FY 2025

Enterprise Value

$460.0M

Debt / EBITDA

8.2x

FY 2025

EV / EBITDA

-8.9x

Employees

—